Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

210 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Trial of Intravenous Immune Globulin in Dermatomyositis.
Aggarwal R, Charles-Schoeman C, Schessl J, Bata-Csörgő Z, Dimachkie MM, Griger Z, Moiseev S, Oddis C, Schiopu E, Vencovský J, Beckmann I, Clodi E, Bugrova O, Dankó K, Ernste F, Goyal NA, Heuer M, Hudson M, Hussain YM, Karam C, Magnolo N, Nelson R, Pozur N, Prystupa L, Sárdy M, Valenzuela G, van der Kooi AJ, Vu T, Worm M, Levine T; ProDERM Trial Group. Aggarwal R, et al. Among authors: oddis c. N Engl J Med. 2022 Oct 6;387(14):1264-1278. doi: 10.1056/NEJMoa2117912. N Engl J Med. 2022. PMID: 36198179 Clinical Trial.
Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis.
Clegg DO, Reda DJ, Harris CL, Klein MA, O'Dell JR, Hooper MM, Bradley JD, Bingham CO 3rd, Weisman MH, Jackson CG, Lane NE, Cush JJ, Moreland LW, Schumacher HR Jr, Oddis CV, Wolfe F, Molitor JA, Yocum DE, Schnitzer TJ, Furst DE, Sawitzke AD, Shi H, Brandt KD, Moskowitz RW, Williams HJ. Clegg DO, et al. N Engl J Med. 2006 Feb 23;354(8):795-808. doi: 10.1056/NEJMoa052771. N Engl J Med. 2006. PMID: 16495392 Free article. Clinical Trial.
Anti-U3 RNP autoantibodies in systemic sclerosis.
Aggarwal R, Lucas M, Fertig N, Oddis CV, Medsger TA Jr. Aggarwal R, et al. Arthritis Rheum. 2009 Apr;60(4):1112-8. doi: 10.1002/art.24409. Arthritis Rheum. 2009. PMID: 19333934 Free article.
Therapeutic approaches in myositis.
Aggarwal R, Oddis CV. Aggarwal R, et al. Curr Rheumatol Rep. 2011 Jun;13(3):182-91. doi: 10.1007/s11926-011-0172-z. Curr Rheumatol Rep. 2011. PMID: 21365210 Review.
Paraneoplastic myalgias and myositis.
Aggarwal R, Oddis CV. Aggarwal R, et al. Rheum Dis Clin North Am. 2011 Nov;37(4):607-21. doi: 10.1016/j.rdc.2011.09.007. Epub 2011 Oct 24. Rheum Dis Clin North Am. 2011. PMID: 22075200 Review.
Therapeutic advances in myositis.
Aggarwal R, Oddis CV. Aggarwal R, et al. Curr Opin Rheumatol. 2012 Nov;24(6):635-41. doi: 10.1097/BOR.0b013e328358ac72. Curr Opin Rheumatol. 2012. PMID: 22955021 Review.
Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: a randomized, placebo-phase trial.
Oddis CV, Reed AM, Aggarwal R, Rider LG, Ascherman DP, Levesque MC, Barohn RJ, Feldman BM, Harris-Love MO, Koontz DC, Fertig N, Kelley SS, Pryber SL, Miller FW, Rockette HE; RIM Study Group. Oddis CV, et al. Arthritis Rheum. 2013 Feb;65(2):314-24. doi: 10.1002/art.37754. Arthritis Rheum. 2013. PMID: 23124935 Free PMC article. Clinical Trial.
Predictors of clinical improvement in rituximab-treated refractory adult and juvenile dermatomyositis and adult polymyositis.
Aggarwal R, Bandos A, Reed AM, Ascherman DP, Barohn RJ, Feldman BM, Miller FW, Rider LG, Harris-Love MO, Levesque MC; RIM Study Group; Oddis CV. Aggarwal R, et al. Among authors: oddis cv. Arthritis Rheumatol. 2014 Mar;66(3):740-9. doi: 10.1002/art.38270. Arthritis Rheumatol. 2014. PMID: 24574235 Free PMC article. Clinical Trial.
210 results